Downregulation of immune response by administering B7RP-2 fusion protein
    1.
    发明授权
    Downregulation of immune response by administering B7RP-2 fusion protein 有权
    通过施用B7RP-2融合蛋白降低免疫反应

    公开(公告)号:US07482325B2

    公开(公告)日:2009-01-27

    申请号:US11229307

    申请日:2005-09-16

    CPC分类号: C07K14/70532

    摘要: The present invention provides B7 Related Protein-2 (B7RP-2) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7RP-2 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7RP-2 polypeptides.

    摘要翻译: 本发明提供B7相关蛋白-2(B7RP-2)多肽和编码该多肽的核酸分子。 本发明还提供选择性结合剂,载体,宿主细胞和用于产生B7RP-2多肽的方法。 本发明进一步提供用于诊断,治疗,改善和/或预防与B7RP-2多肽相关的疾病,病症和病症的药物组合物和方法。